BioCryst Pharmaceuticals, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 167.3M |
| FY2021 | 179.1M |
| FY2022 | 185.9M |
| FY2023 | 192.2M |
| FY2024 | 206.7M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 167.3M |
| FY2021 | 179.1M |
| FY2022 | 185.9M |
| FY2023 | 192.2M |
| FY2024 | 206.7M |